Researching Modifiable and Non-Modifiable Risk Factors Linked to Cognitive Resilience in Alzheimer’s Disease
What do we do?
Our lab focuses on clarifying how alterations in the brain and other biomolecules (such as cerebrospinal fluid β-amyloid) place some cognitively-normal individuals on a pernicious trajectory that culminates in Alzheimer’s dementia. In this context, we are particularly interested in discovering new knowledge concerning the modulation of the link between brain changes and cognitive decline by both modifiable (e.g., cognitively-stimulating activities, physical exercise) and non-modifiable (e.g., genetic vulnerability) factors. Overlaid on this research agenda are investigations of health accessibility, and how such accessibility exacerbates or ameliorates the impact of biomarkers on clinical phenotypes.
We use many techniques in our research, including but not limited to:
This is an accordion element with a series of buttons that open and close related content panels.
MRI and PET Imaging


Cerebrospinal Fluid Collection

Maximal Exercise Testing


Blood-based Biomarkers

Physical Activity Monitoring

Cognitive Testing

We are a part of the larger Wisconsin Alzheimer’s Disease Research Program, which includes both the Wisconsin Alzheimer’s Disease Research Center and the Wisconsin Alzheimer’s Institute.
Our offices are located on UW Madison’s campus within the UW Hospital and WARF. The majority of our research is conducted at the UW Hospital, the Waisman Center, the Wisconsin Institute for Medical Research, and the YMCA.
News Highlights

Bri Breidenbach and Sarah Lose are Featured Guests on Dementia Matters Podcast Episode
Dr. Bri Breidenbach and Sarah Lose were featured guests on a recent episode of the podcast Dementia Matters: Taking Steps to Slow Decline: New Study Examines the Role of Physical Activity on Alzheimer’s Progression They …
January 16, 2026
Ozioma Okonkwo Selected as an Inaugural Fellow of the International Neuropsychological Society
Ozioma Okonkwo has been selected as one of the inaugural Fellows of the International Neuropsychological Society (FINS)! The FINS designation was established to honor members whose dedication and service have made lasting contributions to INS. …
January 9, 2026
Sarah Lose Receives Department of Medicine Staff Award for Exemplifying/Demonstrating the Department’s Core Values
We are thrilled to share that Sarah has been selected as the recipient of the Department of Medicine (DOM) Staff Award for Exemplifying/Demonstrating the Department’s Core Values. This award recognizes individuals whose actions directly support …
January 7, 2026
Ira Frahmand’s Manuscript Accepted for Publication
Ira Frahmand’s manuscript “Age-related alterations in plasma biomarkers of relevance to Alzheimer’s disease are attenuated in KLOTHO KL-VS heterozygotes” has been accepted for publication in Journal of Alzheimer’s Disease (JAD). Congratulations, Ira!
January 5, 2026- More News





